All units carry out the activity of "sending cool and refreshing in summer"
Release time:
2020-08-14
Each unit carries out the "Cool and Cool Summer" activity
News from our newspaper The sun is blazing like fire, the heat is hot, and it is another high temperature season. The subordinate units of Jianfeng Group carried out the activity of "sending cool in summer", which made the employees feel cool in this midsummer.
7# October 21 , Jin Huazhong, secretary of the party Committee of the pharmaceutical company, led relevant personnel to visit the subordinate enterprises Jinxi pharmaceutical factory, qiubin pharmaceutical factory, pharmaceutical company and large pharmacy, sent consolation articles to the employees fighting in the high temperature line on behalf of the pharmaceutical company, and held discussions with the management teams and middle-level cadres of various enterprises respectively, understand the production and operation of the enterprise, the existing problems, the ideological trends of employees and the deployment of the enterprise's heatstroke prevention and cooling work. He expressed his gratitude to all personnel for their efforts in their jobs, and asked companies to actively do a good job in heatstroke prevention and cooling, strengthen job safety publicity and education, prepare heatstroke prevention and cooling drugs, pay attention to the hygiene of the canteen, and earnestly do a good job in heatstroke prevention and cooling. Be practical, prevent heatstroke and other hidden dangers of various accidents, and ensure the safety and health of employees. In pharmaceutical companies and large pharmacies, Jinhua and his party also went deep into the front line of the warehouse to learn about the storage and delivery, and had a cordial conversation with the warehouse staff, urging everyone to pay attention to heatstroke prevention at work and on the way to and from work. On the evening of 7 April 25 , Jinhua middle school leaders also brought consolation articles to the staff dormitory to send cool and refreshing, to understand the staff's working situation and existing difficulties, and asked everyone to pay attention to safety and do a good job in heatstroke prevention and cooling during the high temperature season.
In addition, Zhang Fengliang, general manager of Daye Peak, Li Jinzhi, general manager of Cable Company, and He Songqin, general manager of Peak Pharmacy, also led relevant personnel to the workshop site and various stores respectively to deliver sunstroke prevention and cooling items such as mineral water, watermelon, mung bean and Huoxiang Zhengqi water to the employees, and urged everyone to do a good job of sunstroke prevention and cooling to ensure good physical condition. At the same time, every afternoon during the high temperature period, the headquarters of the large pharmacy also prepared mung bean soup to reduce the summer heat for the employees. (Zhu Yong, Ni Yingzhen, Zheng Nan, Cao Jiankai, Wu Minzhe, Qian Fang)
Another News 7 May 14 , Sang Xiaofeng, General Manager of Southern Peak, went to the front line to deliver cold drinks to employees and held discussions with employees to understand the implementation of heatstroke prevention and cooling work and publicize safety-related matters needing attention. At the production and operation analysis meeting on 7 September 13 , Sang Xiaofeng made a comprehensive deployment on how to do a good job in heatstroke prevention and cooling, from personnel, equipment, production and other aspects, requiring all departments to implement heatstroke prevention and cooling safeguard measures, try to avoid outdoor activities during high temperature periods, shorten continuous working hours for personnel working under high temperature conditions, and carry out heatstroke prevention and cooling safety education for employees, take necessary protective measures to reduce the temperature of the equipment. (Ying Lang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31